The Global Parkinson’s Genetics Program (GP2) is an ambitious program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.
See how many samples are completed and shared with the AMP® PD platform for use.
Collaborate with us and submit a cohort to GP2.
Check out the latest news about GP2.
Read the latest blogs from GP2’s scientists and collaborators.
Find out about GP2’s working groups and their recently accomplished milestones.